Detailed Information on Publication Record
2022
Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations
ONDROUŠKOVÁ, Eva, Michaela BOHÚNOVÁ, Kristýna ZÁVACKÁ, Patrik ČECH, Petra ŠMUHAŘOVÁ et. al.Basic information
Original name
Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations
Authors
ONDROUŠKOVÁ, Eva (203 Czech Republic, belonging to the institution), Michaela BOHÚNOVÁ (703 Slovakia, belonging to the institution), Kristýna ZÁVACKÁ (203 Czech Republic, belonging to the institution), Patrik ČECH (203 Czech Republic, belonging to the institution), Petra ŠMUHAŘOVÁ (203 Czech Republic, belonging to the institution), Miroslav BOUDNÝ (203 Czech Republic, belonging to the institution), Martina ORŠULOVÁ (703 Slovakia, belonging to the institution), Anna PANOVSKÁ (203 Czech Republic, belonging to the institution), Lenka RADOVÁ (203 Czech Republic, belonging to the institution), Michael DOUBEK (203 Czech Republic, belonging to the institution), Karla PLEVOVÁ (203 Czech Republic, belonging to the institution) and Marie JAROŠOVÁ (203 Czech Republic, guarantor, belonging to the institution)
Edition
Frontiers in Oncology, Lausanne, Frontiers Media S.A. 2022, 2234-943X
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30204 Oncology
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.700
RIV identification code
RIV/00216224:14110/22:00126419
Organization unit
Faculty of Medicine
UT WoS
000821921200001
Keywords in English
chronic lymphocytic leukemia; MYC; complex karyotype; 8q24 gain; prognosis
Tags
International impact, Reviewed
Změněno: 11/8/2022 13:02, Mgr. Tereza Miškechová
Abstract
V originále
Chronic lymphocytic leukemia (CLL) with cytogenetics findings, such as complex karyotype and deletions of TP53 or ATM, is associated with adverse clinical outcomes. Additional chromosomal abnormalities further stratify patients into groups with diverse prognoses. Gain of 8q24 is one of the abnormalities considered as prognostically unfavorable. In our study, we performed a FISH analysis in an initial cohort of 303 consecutive CLL patients and determined the frequency of +8q to be 6.3 %. Our analysis confirmed the association with TP53/ATM aberrations and CK, as the frequency of +8q reached 26.7 % in an extended delTP53/ATM+CK cohort. M-FISH analysis enabled the identification of partner chromosomes where the segment of the duplicated 8q arm was localized. More detailed mapping of the gained 8q region using the M-BAND method determined the smallest amplified region 8q23-8qter. We observed significantly shorter overall survival (OS; 9.0 years in +8q-positive vs. 10.6 years in +8q-negative; p=0.02) and detected slightly higher MYC mRNA/protein levels in +8q-positive vs. +8q-negative patients.
Links
MUNI/A/1330/2021, interní kód MU |
| ||
NU21-08-00237, research and development project |
|